Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV

Clinical trial NCT04596878 · COMPLETED

Trial details

NCT number: NCT04596878
Sponsor: Minervax ApS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Group B Streptococcal Infection

Start date: 2020-11-19
Primary completion: 2022-05-18
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.